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Abstract—Artificial Immune System (AIS) is a branch of 
computational intelligence that has gained increasing interest 
among researchers in the development of immune-based models 
and techniques to solve diverse complex computational problems. 
This work focuses on the application of AIS techniques to cancer 
research and specifically for prediction of the recurrence of 
cancer in patients.  The objective is to test AIS models and 
algorithms for cancer research by validation against actual 
cancer datasets. 
Keywords- Artificial immune systems, artificial immune 
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I. INTRODUCTION 
There is an increasing body of research on the application of 
novel artificial intelligence paradigms to the diagnosis and 
prognosis of various kinds of cancer. Typical examples are 
neural networks, fuzzy logic and evolutionary computing. 
Artificial intelligence techniques offer advantages - such as 
adaptation, fault tolerance, learning and human-like behaviour - 
over conventional computing techniques. The rapid increase in 
cancers, such as lung cancer, breast cancer, liver cancer, brain 
cancer and skin cancer resulting from modern life-styles, and 
the parallel exponential growth in affordable computing power 
has lent fresh urgency to researching, finding, developing and 
harnessing pattern recognition and machine intelligence based 
solutions in this arena.   
The objective of this study was to test Artificial Immune 
Systems (AIS) applications, models and algorithms for cancer 
research by validation against actual cancer datasets.  The 
development of intelligent techniques based on Artificial 
Immune Systems that are potentially useful to solve clinical 
cancer problems – in particular, for the prognosis of cancer 
recurrence in patients – is discussed, along with their 
underlying theory and the implementation of applications in 
cancer research. Three popular AIS algorithms are considered, 
and case studies based on actual cancer datasets are presented.  
The outcome, assumptions and limitations of the proposed 
methods with its implications for further research in this area 
draw this paper to its conclusion.    
A. Artificial Immune Systems 
Artificial Immune Systems incorporate many properties of 
natural immune systems, including diversity, distributed 
computation, error tolerance, dynamic learning and adaptation, 
and self-monitoring. The biological immune system has an 
amazing pattern matching ability, used to distinguish between 
foreign cells entering the body (referred to as non-self, or 
antigen) and the cells belonging to the body (referred to as 
self). Immune systems have many characteristics such as 
uniqueness, autonomy, recognition of foreigners, distributed 
detection, and noise tolerance [1]. Artificial immune systems 
can be defined as a computational paradigm that is inspired by 
theoretical immunology, observed immune functions, 
principles and mechanisms [2].  
Three immune mechanisms are primarily used in the 
development of AIS methods. These include the immune 
network theory, clonal selection principles and negative 
selection mechanisms. 
Many AIS based algorithms have been introduced in the 
literature. A survey of the developed AIS algorithms can be 
found in [3] and [12].  
B. AIS and application in Health Sector - Cancer  
ClonalG, V-Detector, and aiNet are algorithms that could, 
in principle, be applied to many domains. In this paper, they 
are applied to applications in cancer research.  
The rest of this report is organized as follows: Section 2 
presents an overview of other conventional classification 
models; Section 3 presents an introduction to three AIS 
models and techniques developed in the literature with 
particular reference made to their application in the Health 
Sector.  It considers three of the most well-known, leading 
AIS algorithms and highlights their relative application areas, 
strengths and weaknesses; Section 4 presents case studies, 
using three datasets specific to cancer and briefly discusses the 
findings and outcome; Section 5 highlights the conclusion of 
this paper and the future work that it suggests. 
 
II. CLASSIFICATION MODELS IN CANCER RESEARCH  
A. Classification Models in Cancer Research - 
Conventional Methods 
Classification is an important research area in cancer 
diagnosis. Reference is made to some outstanding work done in 
this area based on alternative approached. 
1)  Artificial Intelligence Techniques in Breast Cancer 
Diagnosis and Prognosis 
Artificial Intelligence Techniques in Breast Cancer 
Diagnosis and Prognosis [4] describes the development of new 
statistical techniques and artificial intelligence methods that are 
key to recent advances in prognostic and predictive techniques 
in breast cancer research. These cover pathological, intelligent 
and statistical approaches to enable more precise definition of 
disease extent and prediction of tumor behavior and response 
to treatment.  For example, neural networks can be applied to 
effectively recognize and represent the complicated 
dependence of the disease on a range of demographic and 
clinical factors and to distinguish this dependence from the 
noise. Another tool mentioned is MammoNet, a Bayesian 
networks-based tool for breast cancer.  Yet another approach is 
the use of continuous and categorical biological variables as 
prognostic biomarkers for breast cancer patients.  Mention is 
also made of the application of artificial intelligence paradigms 
to computer-assisted interpretation of mammograms and 
cytodiagnosis of breast cancer, including computer vision 
techniques and the current state of the ongoing research 
program in the USA on Xcyt, a new system for remote 
cytological diagnosis of breast cancer. 
2) Computational Intelligence Techniques 
Artificial Intelligence Techniques in Breast Cancer 
Diagnosis and Investigating Human Cancer with 
Computational Intelligence Techniques [5] refers, inter alia, to 
Unsupervised breast cancer discovery: a comparative study on 
model-based and neural computing; Stratification of severity 
of illness indices and out-of-sample validation: a case study 
for breast cancer prognosis; Feature and model selection in 
single voxel spectra for cancer classification; and Statistical 
assessment of MSigDB gene sets in colon cancer.  
3) Fuzzy C-means 
Simulated Annealing Fuzzy Clustering (SAFC) in Cancer 
Diagnosis [6] claims to improve and extend the ideas present 
in Variable String Length Simulated Annealing (VFC-SA) that 
was proposed by Bandyopadhyay. The data from seven oral 
cancer patients tissue samples, obtained through Fourier 
Transform Infrared Spectroscopy (FTIR), were clustered using 
Fuzzy C-means (FCM), VFC-SA and the proposed SAFC 
algorithm. Experimental results provided and comparisons 
made illustrate that the SAFC algorithm is able to find better 
clusters than the other two methods.  
III. AIS ALGORITHMS  
Features of three AIS algorithms are described in brief 
below.  Greater details may be found in the original papers 
cited.   
A. ClonalG Algorithm 
The Clonal Selection principle is the whole process of 
antigen recognition, cell proliferation and differentiation into 
memory cell [7].  Several artificial immune algorithms have 
been proposed in the literature based on the clonal selection 
theory. Castro and Zuben proposed in 2002 a clonal selection 
algorithm named ClonalG for learning and optimization, 
ClonalG generates a population of N antibodies, each 
specifying a random solution for the optimization process. 
During each iteration, some of the best existing antibodies are 
selected, cloned and mutated in order to construct a new 
candidate population. New antibodies are then evaluated and 
certain percentage of the best antibodies is added to the 
original population. Finally a percentage of worst antibodies 
of previous generation are replaced with new randomly create 
ones [8]. 
B. V-Detector Algorithm 
Negative selection is a biological process by which the 
natural immune system generates non-self detectors that do 
not detect self structures.  Similarly, the negative selection 
algorithm generates detector set by eliminating any detector 
candidate that match elements from a group of self samples. 
Negative selection based algorithms have been used in 
different applications areas, such as anomaly detection.   
A Real-Valued Negative Selection Algorithm with 
Variable-Sized Detectors named V-Detector has been 
introduced by Ji and Dasgupta in [9]. It has many 
characteristics such as: simple generation strategy and detector 
scheme, variable sized detectors, coverage estimate and 
boundary-aware technique to interpret the training data set as a 
whole and not as independent points. 
C. aiNet Model 
Several artificial immune network models have been 
proposed based on Jerne’s theory [10] and applied to many 
application domains. Different from the clonal selection 
principle, the immune network theory assumes that the 
immune system maintains a regulated network of cells and 
molecules which maintain interactions between not only an 
antibody and an antigen, but also between antibodies. 
Inspired by the immunological principles including the 
clonal selection, affinity maturation, and immune network 
theory, the artificial immune network model “aiNet” is 
presented by de Castro and Zuben [11]. The aiNet model has 
the capability of reducing redundancy and describing immune 
network structure, including data distribution and clustering. 
IV. CASE STUDIES  
Experiments were carried out to test three of the AIS 
algorithms and explore their capabilities. Three cancer data 
sets were used for testing the classification problem. This 
paper builds on earlier work done by the authors [12] [13]. 
The ClonalG, V-Detector and aiNet algorithms were chosen 
for these case studies and tested on three cancer data sets.  
Initially, the datasets were normalised to unity before being 
fed to the algorithms. Once the data was normalised a five 
percentage of the samples was chosen at random and removed 
from the data set. This then became the testing samples and 
the rest used for the training phase. For each experiment, we 
have repeated the training and the testing phases ten times, in 
which we have used different samples chosen randomly.    
A. Experiment # 1 : Cancer Data set 
The first data set consisted of 693 instances and the number 
of attributes was 12. The predicted output of this dataset 
represents the recurrence status where the value one as an 
output indicates the possibility of the patient getting the cancer 
again in the future.  
For this dataset, the results obtained for accuracy as shown 
in Table I indicating that ClonalG algorithm has achieved 
better average testing accuracy compared to the other two 
algorithms.  
TABLE I  
Round 
 # 
ClonalG V-Detector aiNet 
Train. Test. Train. Test. Train. Test. 
1 0.7178 0.7941 0.8300 0.6765 0.6753 0.7647 
2 0.7204 0.7714 0.8313 0.6857 0.3237 0.2000 
3 0.7143 0.7714 0.8374 0.5143 0.6824 0.6857 
4 0.7015 0.6970 0.8227 0.8182 0.3197 0.3333 
5 0.7193 0.7941 0.8392 0.5294 0.6768 0.7647 
6 0.7167 0.7576 0.8288 0.6364 0.6727 0.8485 
7 0.6980 0.7647 0.8346 0.6176 0.3232 0.2353 
8 0.7238 0.5882 0.8498 0.3529 0.6889 0.5294 
9 0.7056 0.7647 0.8316 0.6471 0.6798 0.7059 
10 0.7102 0.7647 0.8346 0.5588 0.3187 0.3235 
Average 0.7127 0.7468 0.8340 0.6037 0.5361 0.5391 
B. Experiment # 2 : Wisconsin Breast Cancer Dataset 
The Wisconsin breast cancer data set was obtained from the 
University of Wisconsin Hospitals and can be found in [14]. It 
has 699 samples with 9 attributes, where each instance has one 
of two possible classes: benign or malignant. 
The result of this experiment presented in Table II has 
shown that the V-Detector algorithm has achieved a very 
promising accuracy results. Furthermore, the ClonalG 
algorithm also achieved a very good accuracy results compared 
to the previous dataset. However, the results obtained from the 
aiNet algorithm still were unacceptably low and need more 
improvements. 
TABLE II 
Round # 
ClonalG V-Detector aiNet 
Train. Test. Train. Test. Train. Test. 
1 0.8554 0.8571 0.9925 0.9429 0.4820 0.4545 
2 0.8524 0.9429 0.9925 1.0000 0.4812 0.5294 
3 0.8651 0.9063 0.9925 1.0000 0.6607 0.6970 
4 0.8660 0.8571 0.9940 0.9429 0.5375 0.5455 
5 0.8720 0.8000 0.9940 0.9143 0.3509 0.2000 
6 0.8677 0.8235 0.9925 1.0000 0.5678 0.6286 
7 0.8569 0.9429 0.9925 0.9714 0.6370 0.7143 
8 0.8660 0.8286 0.9925 0.9429 0.7481 0.7500 
9 0.8679 0.7576 0.9925 0.9394 0.4932 0.6176 
10 0.8645 0.9143 0.9925 0.9714 0.5783 0.6286 
Average 0.8634 0.8630 0.9928 0.9625 0.5537 0.5765 
C. Experiment # 3 : Haberman’s Survival Dataset  
In this dataset, cases included from a study that was 
conducted at the University of Chicago's Billings Hospital on 
the survival of patients who had undergone surgery for breast 
cancer [14]. It contains 306 instances and 3 attributes, and the 
predicted output represents two classes. The first class 
represents the patient survived 5 years or longer, and the 
second class is for the patient died within 5 years. 
In this experiment, we found also that the V-Detector 
algorithm achieving higher average accuracy rates compared to 
the other two algorithms as shown in Table III. 
TABLE III 
Round 
 # 
ClonalG V-Detector aiNet 
Train. Test. Train. Test. Train. Test. 
1 0.8419 0.9333 0.7629 0.9333 0.3540 0.3333 
2 0.7663 0.5333 0.7869 0.4667 0.7491 0.4667 
3 0.8041 0.8667 0.7629 0.8667 0.2715 0.1333 
4 0.8007 0.6667 0.7766 0.6000 0.4914 0.7333 
5 0.8316 0.8000 0.7663 0.8000 0.2749 0.1333 
6 0.7904 0.6000 0.7698 0.7333 0.6426 0.6000 
7 0.8110 0.6667 0.7732 0.6667 0.7388 0.6000 
8 0.7904 0.8667 0.7663 0.8000 0.7354 0.8667 
9 0.8328 0.6154 0.7713 0.7692 0.2662 0.2308 
10 0.8110 0.5333 0.7801 0.6000 0.7491 0.6000 
Average 0.8080 0.7082 0.7716 0.7236 0.5273 0.4697 
D. Discussion 
Against the background of current research being done, 
both by conventional approaches, as well as by the application 
of AIS algorithms, recent advances have prompted further 
investigation by experimentation of the more promising 
approaches in applying AIS techniques to cancer research, as 
an aid to prognosis, in particular.  
The case studies carried out clearly demonstrate how the 
AIS approaches can be employed in dealing with real world 
problems in health and cancer research.  The three 
experiments conducted to test the ClonalG, V-Detector and 
aiNet algorithms respectively against three cancer datasets 
yielded mixed results. In the first test, the results obtained for 
accuracy were unacceptably low and more improvements 
required for getting better outcomes. On the other hand, a 
better performance result was achieved in the second 
experiment especially with the V-Detector algorithm by 
detecting successfully the number and the clusters for the 
tested dataset. 
 This outcome leads to the conclusion that some of the AIS 
techniques are found to be more suitable for cancer research 
than other AIS approaches.  
V. CONCLUSIONS & FUTURE WORK    
The success rates achieved with AIS models till now 
indicates that there is further need for refinement and 
modifications of the approaches considered to gain greater 
accuracy and reliability to derive even greater benefit in cancer 
research.  The developments of the artificial immune systems 
would benefit not only from the inspiration of biological 
immune principles and mechanisms, but also hybridization 
with other soft computing paradigms, such as neural networks, 
fuzzy logic, and genetic algorithms.  
As a future work, we are aiming to build an ensemble 
model integrating different artificial immune systems 
techniques. Our main objective is to integrate different learning 
and adaptation techniques to overcome individual limitations 
and to achieve synergetic effects through the combination of 
these techniques. 
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